http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Ekso Bionics® to Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021
-
Ekso Bionics Announces Closing of $40 Million Bought Deal Offering
-
Ekso Bionics Increases Previously Announced Bought Deal Offering of Common Stock to $40 Million
-
Ekso Bionics (EKSO) Announces $10 Million Bought Deal Offering Of Common Stock
-
Ekso Bionics Announces $10 Million Bought Deal Offering Of Common Stock
-
Ekso Bionics (EKSO) Reports Preliminary Q4 Results
-
Ekso Bionics Reports Preliminary Fourth Quarter and Full Year 2020 Financial Results
-
Ekso Bionics to Present at the H.C. Wainwright BioConnect 2021 Conference
-
Ekso Bionics (EKSO) Named Mary Ann Cloyd and Rhonda A. Wallen to its Board
-
Ekso Bionics’ Stockholders Elect Mary Ann Cloyd and Rhonda A. Wallen to its Board of Directors
-
Ekso Bionics (EKSO) Announces Continued Adoption of EVO with Flexible Subscription-Based Order from Cloverdale Foods Company
-
Ekso Bionics Announces Continued Adoption of EVO™ with Flexible Subscription-Based Order from Cloverdale Foods Company
-
Ekso Bionics Reports Third Quarter 2020 Results
-
Ekso Bionics Announces EGM Builders as First Customer to Adopt EVO Technology
-
Ekso Bionics® to Report Third Quarter 2020 Financial Results on October 29, 2020
-
Ekso Bionics to Present at the H.C. Wainwright 22nd Annual Global Investment Virtual Conference on September 16, 2020
-
Ekso Bionics (EKSO) Unveils its Latest Assistive Exoskeleton Innovation for Industrial Use
-
Ekso Bionics® Unveils its Latest Assistive Exoskeleton Innovation for Industrial Use
-
Ekso Bionics® to Report Second Quarter 2020 Financial Results on July 30, 2020
-
Army Distaff Foundation-Knollwood is First Life Plan Community to Adopt Ekso Bionics’ Exoskeleton Device for Rehabilitation Following Successful Trial
-
Ekso Bionics (EKSO) Receives FDA Clearance to Market its EksoNR Robotic Exoskeleton for Use with Acquired Brain Injury Patients
-
Ekso Bionics® Receives FDA Clearance to Market its EksoNR™ Robotic Exoskeleton for Use with Acquired Brain Injury Patients
-
Ekso Bionics Announces Closing of $7.89 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
-
Ekso Bionics (EKSO) Announces $7.89 Million Registered Direct Offering of Common Stock, Warrants
-
Ekso Bionics Announces $7.89 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
-
Ekso Bionics® Named “Best Healthcare Robotics Company” in 2020 MedTech Breakthrough Awards Program
-
Ekso Bionics (EKSO) says it's disappointed CFIUS will not allow it to move forward with China joint venture
-
Ekso Bionics Announces CFIUS Determination Regarding China Joint Venture
-
Ekso Bionics Reports First Quarter 2020 Results
-
Ekso Bionics® to Report First Quarter 2020 Financial Results on April 30, 2020
-
Ekso Bionics (EKSO) Reports Prelim. 1Q Revenues Below Consensus; Provides COVID-19 Business Update
-
Ekso Bionics Provides COVID-19 Business Update and Reports Preliminary First Quarter 2020 Financial Results
-
Ekso Bionics (EKSO) Announces Reverse Stock Split
-
Ekso Bionics® Announces Reverse Stock Split
-
Ekso Bionics Reports Fourth Quarter and Year End 2019 Results
-
Ekso Bionics (EKSO) Announces Collaboration with Kindred Healthcare to Pilot EksoNR in Long-Term Acute Care Hospitals
-
Ekso Bionics® Announces Collaboration with Kindred Healthcare to Pilot EksoNR in Long-Term Acute Care Hospitals
-
Ekso Bionics® to Report Fourth Quarter and Full Year 2019 Financial Results on February 27, 2020
-
Post Acute Medical (PAM) Accelerates Adoption of Exoskeleton Rehabilitation with Three Additional EksoNR Devices from Ekso Bionics®
-
Ekso Bionics® Releases its Upgraded EksoPulse Platform, Advanced Cloud-Based Analytics for Robotic Exoskeleton-Assisted Rehabilitation
-
Ekso Bionics® Releases its Upgraded EksoPulse Platform, Advanced Cloud-Based Analytics for Robotic Exoskeleton-Assisted Rehabilitation
-
Ekso Bionics (EKSO) Reports Preliminary Q4 Financial Results
-
Ekso Bionics Reports Preliminary Fourth Quarter and Full Year 2019 Financial Results; Company Achieves Record Fourth Quarter Revenue
-
Ekso Bionics Reports Third Quarter 2019 Results
-
Ekso Bionics Reports Second Quarter 2019 Results
-
Kindred Hospital Rehabilitation Services Expands Pilot of Ekso Bionics®’ EksoGT Exoskeleton to Enhance Stroke Rehabilitation Offering
-
Kindred Hospital Rehabilitation Services Expands Pilot of Ekso Bionics®’ EksoGT Exoskeleton to Enhance Stroke Rehabilitation Offering
-
Ekso Bionics Reports First Quarter 2019 Results
-
Ekso Bionics Reports Fourth Quarter and Year End 2018 Results
-
Ekso Bionics (EKSO) Reports Preliminary Q4 Result

